Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 17.98 | 46.52 |
| PEG Ratio (TTM) | 0.45 | -9.33 |
| P/S Ratio (TTM) | 4.65 | 10.69 |
| P/B Ratio (TTM) | 1.17 | 3.51 |
| P/FCF Ratio (TTM) | 13.80 | 26.03 |
| Price to 5YR AVG Earnings Ratio | N/A | 30.73 |
| Price to 5YR AVG FCF Ratio | N/A | 30.53 |
Profitability (30%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.73% | 5.81% |
| ROE (TTM) | 6.55% | 11.50% |
| Net Profit Margin (TTM) | 25.46% | 18.97% |
| ROIC 5YR AVG | N/A | 8.34% |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 116.62% | 64.91% | N/A |
| Revenue | 0.91% | 11.34% | N/A |
| Net Income | 112.89% | 62.06% | N/A |
| Cash Flow | 2.87% | 43.69% | N/A |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.10 | 1.04 |
| Quick Ratio (TTM) | 4.10 | 1.01 |
| D/E Ratio (TTM) | 0.34 | 0.89 |
| Interest Coverage (TTM) | 3.61 | 6.84 |
| Piotroski F-Score | 6 | 5 |
| Altman Z-Score | 2.31 | 2.30 |
| LTL to 5YR AVG FCF | N/A | 7.97 |
| Shares Outstanding Growth 5YR AVG | N/A | 5.73% |